Patents by Inventor Melissa E. Munroe

Melissa E. Munroe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for Systemic Lupus Erythematosus Disease, and Intensity and Flare
    Publication number: 20230266315
    Abstract: The present invention involves the identification of biomarkers that are predictive of impeding systemic lupus erythematosus (SLE) disease flare. Methods for treating patients so identified are also provided.
    Type: Application
    Filed: September 16, 2022
    Publication date: August 24, 2023
    Applicants: Oklahoma Medical Research Foundation, Oklahoma Medical Research Foundation
    Inventors: Judith A. James, Melissa E. Munroe
  • Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
    Patent number: 11585810
    Abstract: The present invention involves the identification of biomarkers that are predictive of impeding systemic lupus erythematosus (SLE) disease flare. Methods for treating patients so identified are also provided.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: February 21, 2023
    Assignee: OKLAHOMA MEDICAL RESEARCH FOUNDATION
    Inventors: Judith A. James, Melissa E. Munroe
  • SOLUBLE MEDIATORS FOR PREDICTING SYSTEMIC LUPUS ERYTHEMATOSUS ACTIVITY EVENTS
    Publication number: 20220344002
    Abstract: Systemic Lupus Erythematosus is marked by altered immune regulation linked to waxing and waning clinical disease. Embodiments described herein identify sets of biomarkers/mediators and their use for informing and/or predicting a future SLE disease activity event such as an impending SLE flare or SLE-related organ inflammation. Such an approach can be beneficial in the management of lupus.
    Type: Application
    Filed: September 18, 2020
    Publication date: October 27, 2022
    Inventors: Judith Ann JAMES, Melissa E. MUNROE
  • Biomarkers For A Systemic Lupus Erythematosus (SLE) Disease Activity Immune Index That Characterizes Disease Activity
    Publication number: 20210349088
    Abstract: The present invention includes a method of characterizing disease activity in a systemic lupus erythematosus patient (SEE), comprising: obtaining a dataset associated with a blood, serum, plasma or urine sample from the patient, wherein the dataset comprises data representing the level of one or more biomarkers in the blood, serum, plasma or urine sample from each of (b) to (g); at least one innate serum or plasma mediator biomarker; at least one adaptive serum or plasma mediator; at least one chemokine/adhesion molecule biomarker; at least one soluble TNF superfamily biomarker; the inflammatory mediator biomarker SCF; at least one SLE-associated autoantibody specificity biomarker; and calculating a Lupus Disease Activity Immune
    Type: Application
    Filed: September 25, 2019
    Publication date: November 11, 2021
    Inventors: Judith Ann JAMES, Melissa E. MUNROE
  • Biomarkers for Systemic Lupus Erythematosus Disease Activity, and Intensity and Flare
    Publication number: 20200049705
    Abstract: The present invention involves the identification of biomarkers that are predictive of impeding systemic lupus erythematosus (SLE) disease flare. Methods for treating patients so identified are also provided.
    Type: Application
    Filed: July 15, 2019
    Publication date: February 13, 2020
    Inventors: Judith A. James, Melissa E. Munroe
  • BIOMARKERS FOR SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY, AND INTENSITY AND FLARE
    Publication number: 20190390278
    Abstract: The present invention involves the identification of biomarkers that are predictive of impeding systemic lupus erythematosus (SLE) disease flare. Methods for treating patients so identified are also provided.
    Type: Application
    Filed: January 25, 2018
    Publication date: December 26, 2019
    Inventors: Judith A. James, Melissa E. Munroe
  • Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
    Patent number: 10393739
    Abstract: The present invention involves the identification of biomarkers that are predictive of impeding systemic lupus erythematosus (SLE) disease flare. Methods for treating patients so identified are also provided.
    Type: Grant
    Filed: August 11, 2016
    Date of Patent: August 27, 2019
    Assignee: Oklahoma Medical Research Foundation
    Inventors: Judith A. James, Melissa E. Munroe
  • Biomarkers for Systemic Lupus Erythematosus Disease Activity, and Intensity and Flare
    Publication number: 20160349256
    Abstract: The present invention involves the identification of biomarkers that are predictive of impeding systemic lupus erythematosus (SLE) disease flare. Methods for treating patients so identified are also provided.
    Type: Application
    Filed: August 11, 2016
    Publication date: December 1, 2016
    Inventors: Judith A. James, Melissa E. Munroe
  • Biomarkers for Systemic Lupus Erythematosus Disease Activity, and Intensity and Flare
    Publication number: 20150098940
    Abstract: The present invention involves the identification of biomarkers that are predictive of impeding systemic lupus erythematosus (SLE) disease flare. Methods for treating patients so identified are also provided.
    Type: Application
    Filed: October 2, 2014
    Publication date: April 9, 2015
    Applicant: OKLAHOMA MEDICAL RESEARCH FOUNDATION
    Inventors: Judith A. James, Melissa E. Munroe